Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 25, 2025
The Ritedose Corporation is investing more than $17M to further its in-house cGMP laboratory capabilities by expanding its analytical chemistry and microbiology laboratories.
read more
AGC Biologics has announced its partnership with Oculis to manufacture OCS-02, a Phase II investigational drug targeting both Dry Eye Disease and Anterior Uveitis, at its Heidelberg facility.
read more
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the ...
read more
Thursday, December 14, 2017
Medicure has acquired an exclusive license to sell and market a branded cardiovascular drug.
read more
Six CROs have introduced Align Clinical CRO, a new industry standards group dedicated to making it easier for sponsors and CROs to work together during clinical trials.
read more
Wednesday, January 23, 2019
Lannett entered into an agreement with a strategic alliance partner to be the exclusive U.S. distributor of Trientine Hydrochloride Capsules, 250 mg.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
Cerba Research, a leading global clinical trial laboratory services organization owned by Cerba HealthCare, announced today that they have joined forces with ACT Genomics under a joint venture model to create a purpose-built lab facility in Taiwan ...
read more
DCPrime BV and apceth Biopharma GmbH announced they have entered into a strategic manufacturing agreement.
read more
PharmaMar reported to National Securities Market Commission that Chugai Pharmaceutical had exercised its right to terminate without cause the License, Development and Commercialization Agreement for Zepsyre in Japan entered on December 22nd, 2016.
read more
Almac Group has announced additional expansion plans at its Athlone facility.
read more
Adare Pharma Solutions announces that Ludger Roedder has joined the organization as President of Adare Biome.
read more
Tuesday, November 07, 2017
Co-Diagnostics and Synbiotics announced CoSara Diagnostics, a Joint Venture for manufacturing, has broken ground for its manufacturing facility in India.
read more
Monday, February 05, 2018
Cardinal Health announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding.
read more
Thursday, October 11, 2018
West Pharmaceutical Services has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award.
read more